Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 870Neoplasms 657Prostatic Neoplasms 448Lung Neoplasms 361Colorectal Neoplasms 333Carcinoma, Non-Small-Cell Lung 324Leukemia, Myeloid, Acute 256Pancreatic Neoplasms 222Brain Neoplasms 204Multiple Myeloma 202Neoplasm Metastasis 198Carcinoma, Hepatocellular 182Head and Neck Neoplasms 178Glioblastoma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 167Melanoma 156Ovarian Neoplasms 151Squamous Cell Carcinoma of Head and Neck 150Rectal Neoplasms 135Recurrence 133Hematologic Neoplasms 127Sarcoma 125Uterine Cervical Neoplasms 124Stomach Neoplasms 118Glioma 117Triple Negative Breast Neoplasms 116Carcinoma, Renal Cell 116Motor Activity 101Urinary Bladder Neoplasms 99Colonic Neoplasms 99

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Ventricular Dysfunction, Left × 90 days × Clear all
NCT07572175 2026-05-07

SPARTACUS

Icahn School of Medicine at Mount Sinai

Phase 2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, Ventricular Dysfunction, Left, Cardiotoxicity

NCT07515859 2026-04-13

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Yonsei University

Completed
31,486 enrolled

Heart Failure, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡